Ice and flame

Parkhomenko E.V.

Пархоменко Е.В.

ФГАОУ ВО «Алтайский государственный медицинский университет» Минздрава России

Лед и пламя

Авторы:

Пархоменко Е.В.

Подробнее об авторах

Журнал: Non nocere. Новый терапевтический журнал. 2025;(8): 26‑29

Прочитано: 212 раз

Связаться с автором

Оглавление

Как цитировать:

Пархоменко Е.В. Лед и пламя. Non nocere. Новый терапевтический журнал. 2025;(8):26‑29.
Parkhomenko EV. Ice and flame. Non Nocere. New Therapeutic Journal. 2025;(8):26‑29. (In Russ.)

Использование инфографики авторами научных работ

Резюме / Abstract:

Эритромелалгия: симптомы, диагностика, лечение.

Авторы / Authors:

Пархоменко Е.В.

ФГАОУ ВО «Алтайский государственный медицинский университет» Минздрава России

Закрыть метаданные

Литература / References:

Eaton AC, Mayrovitz HN. Primary Erythromelalgia: Historical Perspective and Current Update. Cureus. 2025 Feb 5;17(2): e78576. https://doi.org/10.7759/cureus.78576
Dib-Hajj SD, Yang Y, Waxman SG. Genetics and molecular pathophysiology of Na(v)1.7-related pain syndromes. Adv Genet. 2008;63:85-110. https://doi.org/10.1016/S0065-2660(08)01004-3
Tang Z, Chen Z, Tang B, Jiang H. Primary erythromelalgia: a review. Orphanet J Rare Dis. 2015 Sep 30;10:127. https://doi.org/10.1186/s13023-015-0347-1
Tham SW, Giles M. Current pain management strategies for patients with erythromelalgia: a critical review. J Pain Res. 2018 Aug 30;11:1689-1698. https://doi.org/10.2147/JPR.S154462
Caldito EG, Kaul S, Caldito NG, Piette W, Mehta S. Erythromelalgia. Part I: Pathogenesis, clinical features, evaluation, and complications. J Am Acad Dermatol. 2024 Mar;90(3):453-462. https://doi.org/10.1016/j.jaad.2023.02.071
Kräuchi K, Cajochen C, Werth E, Wirz-Justice A. Functional link between distal vasodilation and sleep-onset latency? Am J Physiol Regul Integr Comp Physiol. 2000 Mar;278(3): R741-8. https://doi.org/10.1152/ajpregu.2000.278.3.R741
Leroux MB. Erythromelalgia: a cutaneous manifestation of neuropathy? An Bras Dermatol. 2018 Jan-Feb;93(1):86-94. https://doi.org/10.1590/abd1806-4841.20187535
Hisama FM, Dib-Hajj SD, Waxman SG. SCN9A Neuropathic Pain Syndromes. 2006 May 6 [updated 2020 Jan 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025.
Naik H, Zhao Y, Forrestal F, Cleall S, Bockbrader H, Chapel S. Population Pharmacokinetics of Vixotrigine in Healthy Volunteers and Subjects with Trigeminal Neuralgia, Painful Lumbosacral Radiculopathy and Erythromelalgia. Eur J Drug Metab Pharmacokinet. 2021 May;46(3):395-404. https://doi.org/10.1007/s13318-021-00678-0
Caldito EG, Caldito NG, Kaul S, Piette W, Mehta S. Erythromelalgia. Part II: Differential diagnoses and management. J Am Acad Dermatol. 2024 Mar;90(3):465-474. https://doi.org/10.1016/j.jaad.2023.02.070
Poterucha TJ, Weiss WT, Warndahl RA, et al. Topical amitriptyline combined with ketamine for the treatment of erythromelalgia: a retrospective study of 36 patients at Mayo Clinic. J Drugs Dermatol. 2013 Mar;12(3):308-310.
Davis MD, Morr CS, Warndahl RA, Sandroni P. Topically Applied Midodrine, 0.2%, an α1-Agonist, for the Treatment of Erythromelalgia. JAMA Dermatol. 2015 Sep;151(9):1025-1026. https://doi.org/10.1001/jamadermatol.2015.0511
Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth. 2011 Oct;107(4):490-502. https://doi.org/10.1093/bja/aer260